Cargando…

Radiotherapy in Pancreatic Cancer: To Whom, When, and How?

SIMPLE SUMMARY: The prognosis of pancreatic cancer is always serious. In most cases, the cancer is diagnosed at an advanced stage. The treatment is based on the combination of many treatment methods. In the presented work, we focus on the analysis of the role of radiotherapy in the radical treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falco, Michał, Masojć, Bartłomiej, Sulikowski, Tadeusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340157/ https://www.ncbi.nlm.nih.gov/pubmed/37444492 http://dx.doi.org/10.3390/cancers15133382

Ejemplares similares

Freeze-all, for whom, when, and how
por: Celada, Paula, et al.
Publicado: (2020)

Non-invasive ventilation in the ED: Whom, When, How?
por: Göksu, Erkan, et al.
Publicado: (2018)

Weaning Maintenance Therapy in Lupus Nephritis: For Whom, When, and How?
por: Jourde-Chiche, Noémie, et al.
Publicado: (2023)

Prone position in ARDS patients: why, when, how and for whom
por: Guérin, Claude, et al.
Publicado: (2020)

Salvage radiotherapy with or without hormone therapy: for whom and when?
por: Carrie, Christian
Publicado: (2017)

Deep Inspiration Breath Hold Reduces the Mean Heart Dose in Left Breast Cancer Radiotherapy
por: Falco, Michał, et al.
Publicado: (2021)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Intradialytic parenteral nutrition for patients on hemodialysis: when, how and to whom?
por: Carrero, Juan J, et al.
Publicado: (2022)

Noninvasive respiratory support for COVID-19 patients: when, for whom, and how?
por: Sullivan, Zachary P., et al.
Publicado: (2022)

Systemic Front Line Therapy of Follicular Lymphoma: When, to Whom and How
por: Pavanello, Francesca, et al.
Publicado: (2016)

Accelerated Partial Breast Irradiation with Intraoperative Radiotherapy Is Effective in Luminal Breast Cancer Patients Aged 60 Years and Older
por: Falco, Michał, et al.
Publicado: (2022)

To immunosuppress: whom, when and how? That is the question with COVID-19
por: Winthrop, Kevin L, et al.
Publicado: (2020)

In search of the optimal proteosome inhibitor. How, when and for whom?
por: Engelhardt, Monika, et al.
Publicado: (2021)

Molecular type and maximal metastasis diameter influence risk of axillary recurrence in breast cancer patients after positive sentinel lymph node biopsy
por: Falco, Michał, et al.
Publicado: (2021)

Editorial: Personalized nutrition with polyphenols—which, for whom, when and how?
por: Weseler, Antje R., et al.
Publicado: (2023)

Pediatric Percutaneous Endoscopic Gastrostomy in Korea - When? By Whom? How?
por: Lee, Yoon
Publicado: (2022)

Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
por: Wu, Jia-Feng
Publicado: (2022)

Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How (Should) We Do It? A Narrative Review
por: Lemiński, Artur, et al.
Publicado: (2023)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022)

Severe Asthma and Biological Therapy: When, Which, and for Whom
por: Rogliani, Paola, et al.
Publicado: (2019)

Capsule Endoscopy in Inflammatory Bowel Disease: When? To Whom?
por: Na, Soo-Young, et al.
Publicado: (2021)

Electroconvulsive therapy following incident bipolar disorder: When, how, and for whom?
por: Salagre, Estela, et al.
Publicado: (2022)

Checkpoint and PARP inhibitors, for whom and when
por: Lee, Jung-Min, et al.
Publicado: (2017)

The “Old” and the “New” Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How
por: Karaiskos, Ilias, et al.
Publicado: (2019)

Cardiomyopathy Induced by Artificial Cardiac Pacing: To Whom, When, Why, and How? Insights on Heart Failure Development
por: Ferrari, Andres Di Leoni, et al.
Publicado: (2023)

How, with whom and when: an overview of CD147-mediated regulatory networks influencing matrix metalloproteinase activity
por: Grass, G. Daniel, et al.
Publicado: (2016)

Heart Transplantation in Congenital Heart Disease: In Whom to Consider and When?
por: Attenhofer Jost, Christine H., et al.
Publicado: (2013)

Oncoplastic Breast Surgery: What, When and for Whom?
por: Macmillan, R. Douglas, et al.
Publicado: (2016)

COVID-19 patients: when and whom to ventilate?
por: Lal, Tusharindra, et al.
Publicado: (2020)

Midwifery continuity of care: A scoping review of where, how, by whom and for whom?
por: Bradford, Billie F., et al.
Publicado: (2022)

Discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia: when and for whom?
por: Atallah, Ehab, et al.
Publicado: (2020)

Dose intensity for induction in acute myeloid leukemia: what, when, and for whom?
por: McCurdy, Shannon R., et al.
Publicado: (2021)

Vitamin D in the Patients with Chronic Kidney Disease: When, to Whom and in Which Form
por: Pavlovic, Drasko, et al.
Publicado: (2015)

Implant retention after acute and hematogenous periprosthetic hip and knee infections: Whom, when and how?
por: Triantafyllopoulos, Georgios K, et al.
Publicado: (2016)

Emergency airway management – by whom and how?
por: Sollid, S. J. M., et al.
Publicado: (2016)

Genetic testing in focal segmental glomerulosclerosis: in whom and when?
por: Tato, Ana María, et al.
Publicado: (2023)

Laparoscopy in Blunt Abdominal Trauma: for Whom? When?and Why?
por: Justin, Viktor, et al.
Publicado: (2017)

Myocardial Revascularization in Patients With Ischemic Cardiomyopathy: For Whom and How
por: Liga, Riccardo, et al.
Publicado: (2023)

DNA and RNA analyses in detection of genetic predisposition to cancer
por: Matyjasik, Joanna, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_nppjjj31g60p44v41j6spnauvs